Arena Pharmaceuticals, Inc. (OQ:ARNA)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ARNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -4,964  
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,472  
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Common Stock S - Open market or private sale -10,836 $55.00
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,964 $37.20
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,472 $32.50
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,000  
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Common Stock S - Open market or private sale -4,500 $55.00
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,000 $35.60
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $19.40
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ARNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -4,964  
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,472  
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Common Stock S - Open market or private sale -10,836 $55.00
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,964 $37.20
Feb 14/20 Feb 13/20 Spector Steven W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,472 $32.50
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,000  
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Common Stock S - Open market or private sale -4,500 $55.00
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,000 $35.60
Feb 14/20 Feb 13/20 Lind Kevin Robert Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $19.40
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ARNA

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)